2Zeng Xiaolan, Mai Xianxia. Li Xingai, et. al. A new tumor inarker - tunior specific growth factors in patients with malignant tumors[J] .International Journal of Mordem Cancer Theraphy 2000,3(3) :20.
3Mitsuo T. Meaning of serai CEA in gastric cancer patients on prognosis[J].J Am coll Surg 1998, 187(1):64～ 68.
4Duffi. Carcinoembryonic antigen as a marker for colorectal cancer[J]. Clin -Chem 2001 Apr 47(4):624～630.
5Itzkowitz SH, Kim YS.New carbohydrate tumor markers [J].Gastroenterology, 1986,92:491.
6Ravikumar TS, Steele G Jr. Conventional and new tumor markers in the diagnosis and therapy of colorectal cancer[J]. Surg Rounds 1987,10:30.
7Himono R, Mori M, Akazawa K, et al.Immunohistocheniical expression of carbohydrate antigen CA199 in colorectal carcinoma[J] .Am- J- Castroenterol, 1994,89(1):101～105.
8Chapman MA. Buckley D, Henson DB. Preoperative carcinoeflibryonic antigen is related to tumor stage and long- term survial in colorectal cancer[J].Br-J-Cancer, 1998 Nov ,78(10):1346～1349.
9Nakagoe T, Sawai T, Ayabe H. Prognostic value of carcinoembryonic antigen (QSA) in tumor tissure of patients with colorectal cancer[J].AnticancerRes, 2001,21(48):3031～3036.
10Forones NM,Tanaka M. CEA and CA199 as prognostic indexes in colorectal cancer[J]. Hepatogastroenterology, 1999,46(26):905～908.
7Sturgeon CM,Hoffman BR,Chan DW,et al.National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice:quality requirements[J].Clin Chem,2008,54(8):1-10.
8Grothey A.A comparison of XELOX with FOLFOX-4 as firstline treatment for metastatic colorectal cancer[J].Nat Clin Pract Oncol,2009,6(1):10-11.
9Seya T,Tanaka N,Shinji S,et al.Lumican expression in advanced colorectal cancer with nodal metastasis correlates with poor prognosis[J].Oncol Rep,2006,16:1225-1230.
10Dbouk HA,Tawil A,Nasr F,et al.Significance of CEA and VEGF asdiagnostic markers of colorectal cancer in lebanese patients[J].Open Clin Cancer J,2007,1:1-5.
